$4.47 Billion is the total value of HHLR ADVISORS, LTD.'s 43 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $550,084,000 | -6.1% | 4,437,953 | 0.0% | 12.30% | -24.6% | |
| TAL | TAL EDUCATION GROUPsponsored ads | $434,738,000 | +5.6% | 11,410,453 | 0.0% | 9.72% | -15.2% | |
| CBPO | CHINA BIOLOGIC PRODS HLDGS I | $262,189,000 | +4.4% | 2,751,200 | 0.0% | 5.86% | -16.2% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $239,235,000 | -7.1% | 1,411,830 | 0.0% | 5.35% | -25.4% | |
| FB | FACEBOOK INCcl a | $227,663,000 | +15.8% | 1,179,600 | 0.0% | 5.09% | -7.0% | |
| SE | SEA LTDsponsored ads | $142,846,000 | +41.2% | 4,300,000 | 0.0% | 3.19% | +13.4% | |
| BPMC | BLUEPRINT MEDICINES CORP | $141,355,000 | +17.8% | 1,498,516 | 0.0% | 3.16% | -5.4% | |
| MLCO | MELCO RESORT AND ENTMT LTDadr | $95,475,000 | -3.9% | 4,395,700 | 0.0% | 2.14% | -22.8% | |
| ESGR | ENSTAR GROUP LIMITED | $94,719,000 | +0.2% | 543,487 | 0.0% | 2.12% | -19.6% | |
| APLS | APELLIS PHARMACEUTICALS INC | $65,370,000 | +29.9% | 2,579,708 | 0.0% | 1.46% | +4.4% | |
| MYOK | MYOKARDIA INC | $48,936,000 | -3.6% | 975,987 | 0.0% | 1.09% | -22.6% | |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $36,111,000 | -12.4% | 3,985,797 | 0.0% | 0.81% | -29.7% | |
| LN | LINE CORPsponsored adr | $33,986,000 | -20.1% | 1,207,763 | 0.0% | 0.76% | -35.9% | |
| GTHX | G1 THERAPEUTICS INC | $29,110,000 | +84.7% | 949,431 | 0.0% | 0.65% | +48.3% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $24,858,000 | -25.0% | 1,835,888 | 0.0% | 0.56% | -39.8% | |
| TME | TENCENT MUSIC ENTMT GROUPspon ads | $22,043,000 | -17.2% | 1,470,491 | 0.0% | 0.49% | -33.5% | |
| GOSS | GOSSAMER BIO INC | $20,794,000 | +2.4% | 937,500 | 0.0% | 0.46% | -17.8% | |
| ARVN | ARVINAS INC | $13,744,000 | +49.0% | 625,000 | 0.0% | 0.31% | +19.5% | |
| SOHU | SOHU COM LTDsponsored ads | $11,228,000 | -15.6% | 802,034 | 0.0% | 0.25% | -32.2% | |
| EIDX | EIDOS THERAPEUTICS INC | $5,551,000 | +32.5% | 178,600 | 0.0% | 0.12% | +6.0% | |
| RCUS | ARCUS BIOSCIENCES INC | $3,379,000 | -36.3% | 425,000 | 0.0% | 0.08% | -48.6% | |
| SFUN | FANG HLDGS LTDadr | $932,000 | -54.0% | 1,500,000 | 0.0% | 0.02% | -62.5% | |
| NEW | PUXIN LTDads | $792,000 | -9.4% | 126,145 | 0.0% | 0.02% | -25.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.